Efficacy and safety of continuous 4‐year telbivudine treatment in patients with chronic hepatitisB-Reference-Cited by-同舟云学术

Efficacy and safety of continuous 4‐year telbivudine treatment in patients with chronic hepatitisB

Published:2012-12-27 Issue:4 Volume:20 Page:
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Wang Y.¹,Thongsawat S.²,Gane E. J.³,Liaw Y.‐F.⁴,Jia J.⁵,Hou J.⁶,Chan H. L. Y.⁷,Papatheodoridis G.⁸,Wan M.⁹,Niu J.¹⁰,Bao W.¹¹,Trylesinski A.¹²,Naoumov N. V.¹²

Affiliation:

1. Institute of Infectious Diseases Southwest Hospital Third Military Medical University Chongqing China

2. Department of Internal Medicine Faculty of Medicine Chiang Mai University Chiang Mai Thailand

3. New Zealand Liver Unit Auckland City Hospital Auckland New Zealand

4. Liver Research Unit Chang Gung Memorial Hospital & University Taipei Taiwan

5. Liver Research Center Beijing Friendship Hospital Capital Medical University Beijing China

6. Hepatology Unit and Department of Infectious Diseases Nanfang Hospital Guangzhou China

7. Medicine and Therapeutics Chinese University of Hong Kong Hong Kong China

8. Academic Department of Medicine Hippokration General Hospital Athens Greece

9. Department of Infectious Diseases ChangHai Hospital of the Second Military Medical University Shanghai China

10. Department of Hepatology First hospital of Jilin University Jilin China

11. Novartis Pharma Corporation East Hanover NJ USA

12. Novartis Pharma AG Basel Switzerland

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.12025

Reference31 articles.

1. European Medicines Agency.Sebivo 600 mg film‐coated tablets: summary of prescribing information. Available at:http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000713/WC500049337.pdf(accessed 13 June 2012).

2. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

3. Report of an International Workshop: Roadmap for Management of Patients Receiving Oral Therapy for Chronic Hepatitis B

4. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

5. Chronic hepatitis B: Update 2009

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the development of HBV small molecule inhibitors;European Journal of Medicinal Chemistry;2023-03

2. Nucleosides and Nucleoside Analogues as Emerging Antiviral Drugs;Mini-Reviews in Organic Chemistry;2021-09-17

3. Evaluation of Clinical Neuropathy After Living Donor Liver Transplant;Experimental and Clinical Transplantation;2021-07

4. Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients;Journal of Clinical Medicine;2021-04-29

5. Predictors of HBeAg loss after nucleos(t)ide analogues treatment for chronic hepatitis B: A preliminary finding;Advances in Digestive Medicine;2020-06